VRDN

Viridian Therapeutics Inc

18.56

+0.53+2.94%

Closed19:34 07/20 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE18.17/18.03

TODAY RANGE18.15-19.23

VOL2.18M

MARKET CAP2.05B

52 WEEK RANGE13.18-34.29

AVG VOL (3M)2.56M

% TURNOVER1.97%

TURNOVER0

P/E (TTM)-4.6895

% RANGE5.96%

EPS(TTM)-3.9578

P/E(FORWARD)-5.0366

P/B2.990

BVPS6.21

DIVIDEND--

P/S26.67

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.02B

SHARES OUTSTANDING110.43M

NEXT EARNINGS08/04-08/10

FREE FLOAT109.11M

LOT SIZE1

EX-DATE11/13/2020

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Wells Fargo Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)
TipRanks·07/14 09:55
“Stay Invested”: Wells Fargo Picks 2 Stocks to Buy as It Stays Bullish on the Market
TipRanks·07/13 13:37
Wedbush Sticks to Its Buy Rating for Viridian Therapeutics (VRDN)
NASDAQ·07/02 14:09
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
TipRanks·07/01 02:05
Viridian Therapeutics (VRDN) Receives a Rating Update from a Top Analyst
Dow Jones·06/30 15:44
Viridian Therapeutics Is Maintained at Outperform by RBC Capital
Dow Jones·06/30 14:09
Viridian Therapeutics Is Maintained at Buy by Truist Securities
Dow Jones·06/30 14:09
Viridian Therapeutics Price Target Raised to $38.00/Share From $35.00 by Truist Securities
Dow Jones·06/30 12:58
Viridian Therapeutics Is Maintained at Outperform by Wedbush
Dow Jones·06/30 12:58
Viridian Therapeutics Price Target Raised to $43.00/Share From $32.00 by Wedbush
Seeking Alpha·06/30 12:30
Viridian Therapeutics: Lumvoa Ready For Prime Time Following FDA Approval
TipRanks·06/30 11:50
Viridian Therapeutics price target raised to $43 from $32 at Wedbush
TipRanks·06/30 11:20
Viridian Therapeutics price target raised to $38 from $35 at Truist
Reuters·06/30 11:16
VIRIDIAN THERAPEUTICS INC <VRDN.O>: WEDBUSH RAISES TARGET PRICE TO $43 FROM $32

Same Industry

Name/Symbol

Change%

Price

VRDN

Regeneron Pharmaceuticals

REGN

-0.67%

672.15

GRDX

BIONTECH

BNTX

-0.09%

91.48

United Therapeutics Corp.

UTHR

+1.25%

535.67

Siga Technologie

SIGA

-3.37%

3.440

Vertex Pharmaceuticals Inc

VRTX

-0.08%

485.65

MRNA

CRL

MEDP

TLPH

CBPO

ICLR

Iqvia Hldgs Inc

IQV

-2.01%

206.26

MOLN

Arcturus Therape

ARCT

-2.10%

6.05

GILD

PRAH

Incyte Corp

INCY

+0.51%

117.25

Aptevo Therapeutics Inc

APVO

+5.33%

4.740

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.